We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
-9.87%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$496M
AUM Growth
-$89.5M
Cap. Flow
-$30.4M
Cap. Flow %
-6.12%
Top 10 Hldgs %
53.18%
Holding
63
New
5
Increased
14
Reduced
30
Closed
4

Top Buys

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$4.38M
2
LIN icon
Linde
LIN
+$3.33M
3
CPRT icon
Copart
CPRT
+$1.75M
4
VVV icon
Valvoline
VVV
+$1.56M
5
MRSH
Marsh
MRSH
+$1.41M

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$7.35M
2
MDT icon
Medtronic
MDT
+$6.6M
3
UNP icon
Union Pacific
UNP
+$5.57M
4
PX
Praxair Inc
PX
+$3.81M
5
WBA
Walgreens Boots Alliance
WBA
+$2.91M

Sector Composition

Rank Sector Weight
1 Healthcare 35.16%
2 Technology 18.59%
3 Financials 12.44%
4 Industrials 12.37%
5 Consumer Staples 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
26
Johnson Controls International
JCI
$85.1B
$5.19M 1.05%
175,160
-39,635
-18% -$1.31M
CHKP icon
27
Check Point Software Technologies
CHKP
$14.3B
$5.17M 1.04%
50,367
-3,633
-7% -$399K
KO icon
28
Coca-Cola
KO
$383B
$4.44M 0.89%
93,720
BTI icon
29
British American Tobacco
BTI
$136B
$4.34M 0.88%
136,359
+12,896
+10% +$502K
SNY icon
30
Sanofi
SNY
$107B
$4.31M 0.87%
+99,300
New +$4.38M
BKR icon
31
Baker Hughes
BKR
$58.3B
$3.77M 0.76%
175,189
+8,311
+5% +$212K
TTE icon
32
TotalEnergies
TTE
$193B
$3.38M 0.68%
64,739
+181
+0.3% +$10.4K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.1T
$3.33M 0.67%
16,323
LIN icon
34
Linde
LIN
$236B
$3.28M 0.66%
+21,044
New +$3.33M
NVO
35
Novo Nordisk
NVO
$228B
$2.84M 0.57%
123,180
-1,176
-0.9% -$26.1K
SWK icon
36
Stanley Black & Decker
SWK
$14.5B
$2.8M 0.56%
23,355
-2,428
-9% -$303K
UL icon
37
Unilever
UL
$142B
$2.68M 0.54%
45,644
-988
-2% -$59.5K
DOX icon
38
Amdocs
DOX
$6.03B
$2.67M 0.54%
45,502
-6,183
-12% -$388K
MDLZ icon
39
Mondelez International
MDLZ
$83.4B
$2.21M 0.45%
55,256
KOF icon
40
Coca-Cola Femsa
KOF
$22.5B
$2.16M 0.43%
35,474
-1,107
-3% -$67K
HOG icon
41
Harley-Davidson
HOG
$2.61B
$2.01M 0.41%
58,982
-5,253
-8% -$206K
KT icon
42
KT
KT
$8.74B
$2M 0.4%
140,284
+15,347
+12% +$222K
WMT icon
43
Walmart Inc
WMT
$909B
$1.86M 0.37%
59,850
CPRT icon
44
Copart
CPRT
$28.5B
$1.69M 0.34%
+141,824
New +$1.75M
DD icon
45
DuPont de Nemours
DD
$18.6B
$1.66M 0.34%
12,277
-692
-5% -$99.4K
TIF
46
DELISTED
Tiffany & Co.
TIF
$1.44M 0.29%
17,880
-1,748
-9% -$178K
BDX icon
47
Becton Dickinson
BDX
$46.4B
$1.42M 0.29%
6,458
VIV icon
48
Telefônica Brasil
VIV
$20.4B
$1.34M 0.27%
112,721
+4,444
+4% +$50.5K
MRSH
49
Marsh
MRSH
$94.3B
$1.34M 0.27%
+16,858
New +$1.41M
SSL icon
50
Sasol
SSL
$7.4B
$1.14M 0.23%
39,017
+15,522
+66% +$503K

Similar funds

Foyston, Gordon, & Payne's Q4 2018 Portfolio in Review

As of Q4 2018, Foyston, Gordon, & Payne held 63 positions worth $496M, down 15% from $586M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $30.4M in Q4 2018, closing 4 positions and reducing 30 holdings. Its most notable exit was L3Harris, an estimated $7.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Sanofi worth $4.31M.

  • Foyston, Gordon, & Payne's largest Q4 2018 buy was Sanofi: 99,300 shares worth $4.31M.
  • Foyston, Gordon, & Payne added most to Valvoline in Q4 2018, an estimated $1.56M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2018 reduction was Medtronic, cutting an estimated $6.6M.
  • Foyston, Gordon, & Payne fully exited L3Harris in Q4 2018, selling an estimated $7.35M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 53% of its $496M portfolio in Q4 2018.
  • Foyston, Gordon, & Payne opened 5 new positions and closed 4 in Q4 2018.
  • Foyston, Gordon, & Payne's portfolio value fell 15% quarter-over-quarter to $496M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2018, filed 8 Feb 2019.